Analysis on the Distribution of TCM Syndromes in convalescent novel coronavirus pneumonia (COVID-19) patients

Study on traditional Chinese Medicine intervention Program of COVID-19 's convalescence and sequelae based on COVID-19 case Registration system

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000038739

Enrollment

Unknown

Registered

2020-09-30

Start date

2020-08-01

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. According to the "COVID-19 diagnosis and treatment Plan-trial Seventh Edition" jointly issued by the State Health Commission and the State Administration of traditional Chinese Medicine on March 3, 2020, it is in line with COVID-19 's convalescent patients; 2. Informed consent to this study, volunteer to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Those who are participating in other clinical trials; 2. Those who cannot cooperate with the original serious diseases such as brain, heart, liver, kidney and hematopoietic system, malignant tumors and mental and neurological disorders can not cooperate.

Design outcomes

Primary

Measure	Time frame
Syndrome distribution law;	—

Countries

China

Contacts

Public ContactChengxiang Wang

Beijing University of Chinese Medicine Third Affiliated Hospital

wang601@vip.sina.com+86 18612922358

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026